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Abstract
Isolated intact myocytes can be used to investigate contractile mechanisms
and to screen new therapeutic compounds. These experiments typically
require euthanizing an animal and isolating fresh cells each day or analyzing
cultured myocytes, which quickly lose their rod-shaped morphology. Recent
data suggest that the viability of canine myocytes can be prolonged using low
temperature and N-benzyl-p-toluene sulfonamide (an inhibitor of skeletal
myosin ATPase). We performed similar studies in rat myocytes in order to
test whether the cardiac myosin ATPase inhibitors 2,3-Butanedione monoxime
(BDM) and blebbistatin help to maintain cell-level function over multiple
days. Myocytes were isolated from rats and separated into batches that were
stored at 4°C in a HEPES-buffered solution that contained 0.5 mmol L1
Ca2+ and (1) no myosin ATPase inhibitors; (2) 10 mmol L1 BDM; or (3)
3 lmol L1 blebbistatin. Functional viability of myocytes was assessed up to
3 days after the isolation by measuring calcium transients and unloaded short-
ening profiles induced by electrical stimuli in inhibitor-free Tyrode’s solution.
Cells stored without myosin ATPase inhibitors had altered morphology (fewer
rod-shaped cells, shorter diastolic sarcomere lengths, and membrane blebbing)
and were not viable for contractile assays after 24 h. Cells stored in BDM
maintained morphology and contractile function for 48 h. Storage in blebbist-
atin maintained cell morphology for 72 h but inhibited contractility. These
data show that storing cells with myosin ATPase inhibitors can extend the via-
bility of myocytes that will be used for functional assays. This may help to
refine and reduce the use of animals in experiments.
Introduction
Intact myocytes are frequently used to investigate the
molecular mechanisms that underlie contraction and to
screen potential therapies for cardiac disease (King et al.
2011; Malik and Morgan 2011; Aronson and Krum 2012;
Campbell et al. 2013; Chung and Campbell 2013). Many
experiments can be performed using myocytes that have
been cultured but these cells typically exhibit altered mor-
phology (e.g., nonrectangular shape and misaligned sarco-
meres) that make it difficult to assess contractility. Thus
groups studying how mutations and/or drugs alter cal-
cium transients and cell shortening often isolate fresh cells
on a nearly daily basis.
Isolation procedures require euthanizing an animal but
often yield millions of cells. Assays of contractile proper-
ties can be time-consuming so many groups will study
only a few tens of cells on the day of the isolation. The
remaining cells are unlikely to be functional the following
day and are commonly discarded. If the left-over cells
could be preserved and studied for several days in a row,
researchers could reduce the number of animals that need
to be euthanized for the experiments. The researchers
would also save time and resources. A method that
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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prolongs the viability of myocytes for use in functional
assays could thus accelerate research relating to cardiac
disease.
Recently, Abi-Gerges et al. (2013) reported that the
morphology and shortening profiles of canine myocytes
could be maintained for at least 1 week by storing them
at low temperature in a solution containing N-benzyl-p-
toluene sulfonamide (BTS). This compound was previ-
ously shown to inhibit the ATPase of skeletal muscle
myosin (Cheung et al. 2002).
We performed experiments to test whether a similar
approach can preserve the morphology and prolong the
contractile viability of rat myocytes which have faster maxi-
mally activated ATPase rate than canine cells. Instead of
BTS, we chose to test 2,3-butanedione 2-monoxime (BDM)
and blebbistatin, because these compounds are already used
by many investigators to inhibit myosin ATPase in rodent
cardiac cells. BDM is a myosin II ATPase inhibitor (Louch
et al. 2011), which can exhibit phosphatase activity (Wig-
gins et al. 1980). It is commonly used to inhibit contractil-
ity during isolation of myocytes, which is thought to
improve cell yield (Peeters et al. 1995; Louch et al. 2011).
Blebbistatin is an ATPase inhibitor that reduces the actin-
binding affinity of myosin (Kovacs et al. 2004). It has been
used to uncouple contractility from electrical stimulation
and calcium release (Farman et al. 2008) and to investigate
passive cardiac mechanics (King et al. 2011).
Materials and Methods
Animals
Eight female Sprague–Dawley rats (7  1 months of age,
Charles River Laboratories) were used in this study. All
animal use was approved by the Institutional Animal Use
and Care Committee of the University of Kentucky.
Myocyte isolation
Myocytes were isolated as previously described (Louch
et al. 2011; Campbell et al. 2013; Chung and Campbell
2013). Briefly, rats were heparinized (700 U IP), anesthe-
tized (Sodium Pentobarbital 50 mgkg1 IP), and killed by
exsanguination. Excised hearts were immediately placed in
a cold (4°C), oxygenated (>10 ppm) Perfusion Solution
(PS; in mmol L1: 113 NaCl, 4.7 KCl, 0.6 KH2PO4, 1.2
MgSO4, 12 NaHCO3, 10 KHCO3, 10 HEPES, 30 Taurine,
5.5 glucose) with 10 mmol L1 BDM. The aortas were then
cannulated so that the hearts could be flushed until they
were clear of blood. This procedure was started using 5 mL
of the cold PS plus 10 mmol L1 BDM and finished with
5 mL of warm PS plus 10 mmol L1 BDM (37°C, via grav-
ity perfusion at 90 mmHg pressure).
The hearts were then perfused with digestion solution
(PS with 2 lmol L1 Ca2+ and 4.8 mg of Liberase THTM
(Roche, Indianapolis, IN), with 10 mmol L1 BDM) for
~10 min before being removed from the cannula. The tis-
sue was then minced using small ceramic-coated scissors,
lightly agitated to dissociate cells, and then resuspended
in an enzyme stopping solution (PS with 10% fetal
bovine serum and 12 lmol L1 Ca2+) for 5 min. Cells
were allowed to settle by gravity into a pellet at the bot-
tom of the vial. The supernatant was then drawn off and
replaced with a second enzyme stopping solution (perfu-
sion solution with 5% fetal bovine serum and 12 lmol
L1 Ca2+). Extracellular Ca2+ was then raised to
0.5 mmol L1 using a four-step calcium ladder. The
products of this isolation were then divided between at
least 24 Eppendorf tubes. Each tube contained 25–75 lL
of cells in a total volume of 500 lL. All solutions were
pH = 7.3 at room temperature.
Myocyte storage
Tubes that would be stored were allowed to settle and
their supernatant was replaced by one of three storage
solutions: (1) 500 lL PS with 0.5 mmol L1 Ca2+, (PS
group) 2) 500 lL PS with 0.5 mmol L1 Ca2+, and
10 mmol L1 BDM (PS + BDM group), or 3) 500 lL PS
with 0.5 mmol L1 Ca2+and 3 lmol L1 blebbistatin (PS
+ Bleb) group. The tubes were stored at 4°C. No solution
changes were performed during storage. BDM was
acquired from Sigma Aldrich (B0753) and blebbistatin
was acquired from CalbioChem (203390).
Myocyte morphology
Cell morphology was assessed by resuspending cells from
a randomly selected Eppendorf tube and pipetting a
droplet onto a microscope slide. Cells were then imaged
using a standard laboratory microscope. Cell shape, pres-
ence of membrane blebbing, and clarity of the striation
pattern were assessed qualitatively. The proportion of
rod-shaped cells (i.e.,, those cells with a length/width ratio
of at least 2.5) was quantified and compared to the pro-
portion that was measured on the day that the cells were
isolated. Approximately 300 cell-like bodies were counted
in each condition (minimum 88, maximum 884 cells per
condition) from four isolations.
Myocyte function
Samples were prepared for functional measurements by
allowing the myocytes to settle and replacing the superna-
tant with fresh PS containing 0.5 mmol L1 Ca2+ but no
myosin ATPase inhibitors. This was repeated three times
2015 | Vol. 3 | Iss. 6 | e12445
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with 20 min in between to remove as much of the initial
storage medium as possible. After the final solution
change, extracellular Ca2+ was raised to 1 mmol L1 and
the cells were allowed to acclimate for at least 1 h.
Functional measurements were performed in an oxygen-
ated (>10 ppm) Tyrode’s solution (in mmol L1: 140 NaCl,
5.4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, pH
7.3) as previously described (Campbell et al. 2013; Chung
and Campbell 2013). Briefly, 40 lL of a solution containing
calcium tolerant cells was added to 230 lL of Fura loading
solution (Tyrode’s solution with 0.02% pluronic acid and
2 lmol L1 of the cell permeable fluorescent calcium
indicator Fura-2AM (Life Technologies, Grand Island,
NY)). Loading solutions were mixed fresh on each experi-
mental day and allowed to incorporate into the cytosol for
15 min before assays were performed. Loading was ended
by transferring 30 lL of cells into 150 lL of fresh Tyrode’s
solution. After a further 15 min, these cells were transferred
to an experimental chamber that was continuously perfused
with oxygenated Tyrode’s solution. Temperature was con-
trolled at 25°C using an in-line heater (HPRE2, Cell Micro-
Controls, Norfolk, VA) and a custom 1.5 watt heating
source formed from power resistors embedded around the
chamber. After settling to the cover glass, cells were contin-
uously paced at 0.5 Hz using a 5 msec duration bipolar
excitation.
Measurements were performed using apparatus that
has been described previously (Campbell et al. 2013;
Chung and Campbell 2013). Briefly, sarcomere length
shortening profiles were measured using a high speed
video camera and converted to an analog voltage signal
using a D/A converter (901A HVSL and 903A, Aurora
Scientific, Aurora, Ontario Canada). Calcium transients
were measured by monitoring Fura-2 fluorescence at
510 nm in response to dual wavelength excitation at 340
and 380 nm (Ratiomaster DeltaRAM X illuminator and
D-104 Photometer, Photon Technology International, Bir-
mingham, NY). Excitation switching, temperature, and
pacing were computer controlled using a customized pro-
gram written in MATLAB (Mathworks, Natick, MA) and
16 bit data acquisition cards (DAP5216a, Microstar Labo-
ratories, Bellevue, WA) operating at 2 kHz.
Calcium transients and unloaded shortening profiles
were analyzed offline using custom-written software
developed in MATLAB. Calcium fluorescence ratios were
calculated by dividing the emission (510 nm) intensity
values recorded during successive excitations by 340 nm
and 380 nm wavelengths. Ratios and sarcomere length
transients were filtered using Savitzky–Golay filters. The
parameters that are reported here for calcium transients
are as follows: Fura signal amplitude, time to peak, time
to 50% relaxation, and tau (time constant of exponential
decay) (Fig. 1). The parameters that are reported for
sarcomere length profiles are as follows: diastolic length,
shortening amplitude, time to peak shortening, and time
to 50% relaxation time.
Sarcomere length records were time-shifted to allow for
a fixed 15 ms delay introduced by the video analysis sys-
tem. Data from individual myocytes were excluded from
further analysis if their calcium transient or unloaded
shortening profile was prolonged (>0.5 sec) or if calcium
transients were not detected.
Some of the cells that had been stored in blebbistatin
for 2 or 3 days were briefly exposed to blue light to test
whether blebbistatin could be photoinactivated. These
measurements were performed by measuring the function
of several cells, exposing them to 460 nm light from a
light emitting diode positioned 5 cm from the cells for
60 sec, and then repeating the functional measurements.
Statistics
Statistical analyses were performed using the GLM function
in SAS (SAS Institute Inc, Cary, NC). Post hoc comparisons
against control values were performed using Dunnett’s
tests. Analyses of the effects of photoinactivation used a
paired design. P-values less than 0.05 were considered sig-
nificant. Values are reported as mean  SEM.
Results
Myocyte morphology
Freshly isolated myocytes that were tolerant to calcium
had well-defined edges, clear striation patterns, and a
Half relaxtion time
Time to peak
1 sec
0.1   m
Diastolic SL
SL shortening 
Half relaxation time
Fura amplitudeTau
Time to peak
Fura-2
signal
[AU]
Sarcomere
length
[   m]µ
μ
Figure 1. Parameters reported in this study.
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distinctive rod-like shape (length to width ratio more
than 2.5) (Fig. 2).
Cells that were stored at 4°C without myosin ATPase
inhibitors showed characteristic blebbing at their edges
and had resting sarcomere lengths below 1.7 lm after
24 h. The normalized fraction of rod-shaped cells was
0.16  0.08 after 24 h (Fig. 3; Supplemental Fig. S1 and
S2) and zero within 3 days.
Cells that were stored in either 10 mmol L1 BDM or
3 lmol L1 blebbistatin had sharper cell edges, more
defined striation patterns, and were more likely to be
rod-shaped (Fig. 3) than cells stored without myosin
ATPase inhibitors. Blebbistatin was more effective at
maintaining these parameters than BDM. Sharp cell edges
were still apparent in a batch of cells that were stored in
blebbistatin at 4°C for 6 days (data not shown). Cells
that were stored in BDM became significantly more
ball-shaped or showed signs of short SL and blebbing by
72 h.
Cell function
Calcium transients and unloaded shortening profiles for
freshly isolated myocytes were similar to those measured
in previous studies from our laboratory (Campbell et al.
2013; Chung and Campbell 2013). We were unable to
record calcium transients or shortening profiles from cells
that were stored for 24 h or more without myosin
ATPase inhibitors.
Storage with 10 mmol L1 BDM prolonged the viabil-
ity of myocytes (PS + BDM, Fig. 4). There were slight
changes in the amplitude and timing of the Ca2+ tran-
sients after 24 h in BDM but contractile parameters (rest-
ing sarcomere length, shortening amplitude, time to peak
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shortening, and time to 50% relaxation) did not differ
from control (Day 0) values after 2 days of storage. Rest-
ing sarcomere length and shortened amplitude both
decreased after 3 days but the kinetics of the contraction
remained unchanged.
Storing cells in 3 lmol L1 blebbistatin was less effec-
tive at maintaining myocyte function than storing cells in
BDM. As shown in Figure 5, calcium transients were sta-
tistically different from control values after just 24 h of
storage. The amplitude of shortening was also signifi-
cantly reduced at this time-point and continued to
decline in subsequent days.
Prior experiments have shown that blebbistatin can be
photoinactivated by blue light (Sakamoto et al. 2005;
Kabaeva et al. 2008). We studied 12 myocytes that had
previously been stored in blebbistatin for 2 days before
and after exposure to blue light to test whether light
could be used to reverse the contractile inhibition. As
shown in Fig. 6, 60 sec of exposure to 460 nm light
partially reversed some of the effects of blebbistatin on
cell shortening and calcium.
Discussion
This report shows that storage at 4°C with compounds
that inhibit myosin ATPase can preserve the morphology
and contractile function of isolated rat myocytes. Low
temperature alone is insufficient. We did not test whether
inhibiting myosin ATPase at room and physiological tem-
peratures is sufficient to prolong function.
To our knowledge, our manuscript presents the first
data quantifying contractile function and calcium han-
dling in rat myocytes that have been stored for several
days. Prior studies assessing storage options have focused
on electrophysiology and used cells that were plated in
cell culture and maintained at 37°C in incubators. This
has some limitations. For example, cells typically lose
their rod-like shape under normal culture conditions.
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Figure 4. Effects of storage in 10 mmol L1 BDM on calcium handling and contractile function.
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Kabaeva et al. (2008) showed that this transition could be
prevented using blebbistatin which is similar to our find-
ing using noncultured cells. It is interesting to note that
Kabeava et al. changed their bathing medium every 24 h
while our protocol was much simpler. We left our cells in
the refrigerator at 4°C until they were prepared for con-
tractile assays. In the long run, our technique might be
easier for most laboratories to implement.
Another complication of culturing cells is that the
alignment of myofibers changes with the stiffness of the
substrate that the cells are plated on (Hazeltine et al.
2012; Dasbiswas et al. 2015). These structural changes
might alter contractile parameters and thus complicate
the interpretation of experimental results.
Cell function after storage using BDM
BDM maintained the functional viability of rat myo-
cytes for 2 days. Parameters quantifying the unloaded
sarcomere length shortening profiles were not statistically
different from control values for at least 48 h (Fig. 4).
Only after 3 days of storage were diastolic sarcomere
length and shortening amplitude attenuated. Calcium
transients exhibited some statistically significant changes
with storage time. For example, the time to 50% relaxa-
tion was prolonged after 24 h. The amplitude of the Fura
signal also increased. Some of these effects may be related
to changes in the way that cells load Fura after prolonged
storage.
Although we did not specifically quantify cell mem-
brane integrity using Trypan blue or similar staining tech-
niques, we noticed a potential relationship between
blebbing and cell viability. Rod-shaped cells with patent
edges produced consistent, repeatable functional measure-
ments. In contrast, myocytes that exhibited blebbing at
their edges (Fig. 2, Day 2 PS + BDM) more rapidly tran-
sitioned from their original rod-like shapes to amorphous
balls when paced. Nonetheless, rod-shaped cells were
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Figure 5. Effects of storage in 3 lmol L1 blebbistatin on calcium handling and contractile function.
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viable in that they responded to the pacing stimulus even
after several days of storage.
We limited the concentration of BDM to 10 mmol L1
because it is just above the IC50 of force inhibition (Brix-
ius et al. 2000) and typical of the conditions used to inhi-
bit contractility in rodent myocytes (King et al. 2011;
Campbell et al. 2013; and Chung and Campbell 2013).
We did not test if increasing the concentration of BDM
would improve cell viability. However, these experiments
would need to be planned carefully because BDM’s
phosphatase activity might produce unforeseen effects
(Wiggins et al. 1980).
In summary, storage in BDM at 4°C maintains the
contractile properties of myocytes for 48 h after isolation.
There are some minor changes in Ca2+ transients after
24 h but these may relate to changes in dye loading. The
ability to use cells beyond the day of isolation could
accelerate studies investigating the effects of small mole-
cules on cardiac contractility (Malik et al. 2011).
Cell function after storage using
blebbistatin
Storing myocytes in solutions containing blebbistatin
maintained cell morphology for several days (Fig. 2) but
altered calcium handling and contractile function (Fig. 5).
Time to peak calcium became shorter while Ca2+ relaxa-
tion was prolonged. Sarcomere length transients also
became faster with storage but the most important func-
tional difference was the progressive decline in shortening
amplitude. The impaired shortening is broadly consistent
with data reported for canine myocytes in a supplement
published by Abi-Gerges et al. (2013).
It is interesting that storage in blebbistatin reduced
contractility in these tests because the drug is membrane
permeable and the solution changes that were performed
before the contractile assays are calculated to reduce the
drug’s concentration below 3 nmol L1. This is well
below the IC50 for blebbistatin which is ~2 lmol L1
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Figure 6. Effects of exposure to 460 nm light on calcium handling and contractile function in myocytes stored in 3 lmol L1 blebbistatin.
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(Limouze et al. 2004). Straight et al. (2003) have also
shown that the effects of blebbistatin on cell cycling and
cell division can be reduced by washout. In contrast,
studies using cardiac cells suggest that the effects of
blebbistatin are nearly irreversible by washout (Farman
et al. 2008; Abi-Gerges et al. 2013). This suggests that
blebbistatin dissociates from the myosin head at a very
low rate.
We performed a simple test to investigate whether the
inhibitory effects of blebbistatin on contraction could be
relieved by modifying the compound with blue light
(460 nm) (Kolega 2004; Sakamoto et al. 2005). As shown
in Figure 6, 60 sec of exposure partially reversed the
inhibitory effects of blebbistatin. Increasing the exposure
time, or using a light with a higher power, might enhance
the reversal but could also cause cell damage and death
(Kolega 2004; Sakamoto et al. 2005).
Limitations
We performed qualitative assessments of cell morphology
and quantitative assays of contractile function and cal-
cium handling. We did not examine other cell structures,
such as t tubule networks.
We also limited our study to rat myocytes because
these are the preparations that our laboratory analyzes
most frequently. Mouse myocytes are probably the most
commonly used cell-type in cardiac studies and it would
be interesting to see whether BDM and blebbistatin can
prolong the viability of these preparations as well. It
would also be useful to test whether BTS, the myosin
ATPase inhibitor used by Abi-Gerges et al. (2013) in
their study of canine myocytes, is effective in rodent
cells as well. Because our study focused on the myosin
inhibitors that are most commonly used with cardiac
muscle (BDM and Blebbistatin) we did not perform this
comparison.
Summary
These data show that BDM can be used to maintain the
morphology and prolong the contractile viability of rat
cardiac myocytes for 48 h. Research groups may be able
to leverage our findings and study cells for several days
after they have been isolated. This will increase the effi-
ciency and cost-effectiveness of experiments by reducing
the number of isolations. It will also refine and reduce
the use of animals in experiments investigating cardiac
function (Russell and Burch 1959).
Conflict of Interest
None declared.
References
Abi-Gerges, N., A. Pointon, G. F. Pullen, M. J. Morton, K. L.
Oldman, D. Armstrong, et al. 2013. Preservation of
cardiomyocytes from the adult heart. J. Mol. Cell. Cardiol.
64:108–119.
Aronson, D., and H. Krum. 2012. Novel therapies in acute and
chronic heart failure. Pharmacol. Ther. 135:1–17.
Brixius, K., U. Mehlhorn, W. Bloch, and R. H. Schwinger.
2000. Different effect of the Ca(2 + ) sensitizers EMD 57033
and CGP 48506 on cross-bridge cycling in human
myocardium. J. Pharmacol. Exp. Ther. 295:1284–1290.
Campbell, S. G., P. Haynes, W. Kelsey Snapp, K. E. Nava, and
K. S. Campbell. 2013. Altered ventricular torsion and
transmural patterns of myocyte relaxation precede heart
failure in aging F344 rats. Am. J. Physiol. Heart Circ.
Physiol. 305:H676–H686.
Cheung, A., J. A. Dantzig, S. Hollingworth, S. M. Baylor, Y. E.
Goldman, T. J. Mitchison, et al. 2002. A small-molecule
inhibitor of skeletal muscle myosin II. Nat. Cell Biol.
4:83–88.
Chung, C. S., and K. S. Campbell. 2013. Temperature and
transmural region influence functional measurements in
unloaded left ventricular cardiomyocytes. Physiol. Rep. 1:
e00158.
Dasbiswas, K., S. Majkut, D. E. Discher, and S. A. Safran.
2015. Substrate stiffness-modulated registry phase
correlations in cardiomyocytes map structural order to
coherent beating. Nat. Commun. 6:6085.
Farman, G. P., K. Tachampa, R. Mateja, O. Cazorla, A.
Lacampagne, and P. P. de Tombe. 2008. Blebbistatin: use as
inhibitor of muscle contraction. Pfl€ugers Arch. Eur. J.
Physiol. 455:995–1005.
Hazeltine, L. B., C. S. Simmons, M. R. Salick, X. Lian, M. G.
Badur, W. Han, et al. 2012. Effects of substrate mechanics
on contractility of cardiomyocytes generated from human
pluripotent stem cells. Int. J. Cell Biol. 2012:508294.
Kabaeva, Z., M. Zhao, and D. E. Michele. 2008. Blebbistatin
extends culture life of adult mouse cardiac myocytes and
allows efficient and stable transgene expression. Am. J.
Physiol. Heart Circ. Physiol. 294:H1667–H1674.
King, N. M. P., M. Methawasin, J. Nedrud, N. Harrell, C. S.
Chung, M. Helmes, et al. 2011. Mouse intact cardiac
myocyte mechanics: cross-bridge and titin-based stress in
unactivated cells. J. Gen. Physiol. 137:81–91.
Kolega, J. 2004. Phototoxicity and photoinactivation of
blebbistatin in UV and visible light. Biochem. Biophys. Res.
Commun. 320:1020–1025.
Kovacs, M., J. Toth, C. Hetenyi, A. Malnasi-Csizmadia, and J.
R. Sellers. 2004. Mechanism of blebbistatin inhibition of
myosin II. J. Biol. Chem. 279:35557–35563.
Limouze, J., A. F. Straight, T. Mitchison, and J. R. Sellers.
2004. Specificity of blebbistatin, an inhibitor of myosin II.
J. Muscle Res. Cell Motil. 25:337–341.
2015 | Vol. 3 | Iss. 6 | e12445
Page 8
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Preservation of Intact Myocyte Function C. S. Chung et al.
Louch, W. E., K. A. Sheehan, and B. M. Wolska. 2011.
Methods in cardiomyocyte isolation, culture, and gene
transfer. J. Mol. Cell. Cardiol. 51:288–298.
Malik, F. I., and B. P. Morgan. 2011. Cardiac myosin
activation part 1: from concept to clinic. J. Mol. Cell.
Cardiol. 51:454–461.
Malik, F. I., J. J. Hartman, K. A. Elias, B. P. Morgan, H.
Rodriguez, K. Brejc, et al. 2011. Cardiac myosin activation:
a potential therapeutic approach for systolic heart failure.
Science 331:1439–1443.
Peeters, G. A., M. C. Sanguinetti, Y. Eki, H. Konarzewska, D.
G. Renlund, S. V. Karwande, et al. 1995. Method for
isolation of human ventricular myocytes from single
endocardial and epicardial biopsies. Am. J. Physiol. 268:
H1757–H1764.
Russell, W. M. S., and R. L. Burch. 1959. The principles of
humane experimental technique. Methuen, London.
Sakamoto, T., J. Limouze, C. A. Combs, A. F. Straight,
and J. R. Sellers. 2005. Blebbistatin, a myosin II
inhibitor, is photoinactivated by blue light. Biochemistry
44:584–588.
Straight, A. F., A. Cheung, J. Limouze, I. Chen, N. J.
Westwood, J. R. Sellers, et al. 2003. Dissecting temporal and
spatial control of cytokinesis with a myosin II Inhibitor.
Science 299:1743–1747.
Wiggins, J. R., J. Reiser, D. F. Fitzpatrick, and J. L. Bergey.
1980. Inotropic actions of diacetyl monoxime in
cat ventricular muscle. J. Pharmacol. Exp. Ther. 212:217–
224.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Low magnification images showing rod- and
nonrod-shaped cells.
Figure S2. Cell survival counts.
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